Business Assets for Sale

This building is a neo-renaissance complex, which has 3 floors, and over 6,000 sq. m. of commercial space. The neighborhood of this building is a busy place where 50,000 people move around each day. This is a strategically located property that can be used for commercial purposes. It is a 100 years old historical building. This building was owned by a telecommunications company, who invested over €7.5M to restore and renovate the property. The building is now ready and put up for public sale. This property can be used as a hotel, service premises, co-working for freelancers, offices, meeting places or offices for the creative industry.

The company is selling perpetual usage rights of an AI platform that analyzes microbiome and health data to deliver personalized nutrition and wellness plans. - Partners can deploy and white-label the platform locally, offering premium, data-driven health solutions under their own brand. - The sale includes the proprietary core AI algorithms and source code for the microbiome-based precision diet technology. - Partners receive the right to unlimited API access and the ability to customize and train the AI with local data, ensuring relevance and effectiveness in their market. - The license also grants the right to localized deployment on the partner's local servers for compliance and security, and the autonomy to operate and brand the AI as their own. - The capacity of the AI model is virtually unlimited as it is scalable to the partner's server infrastructure, and its condition is excellent, being actively maintained by us. - The tangible assets required for the operation are minimal and fall primarily under the partner's operational responsibility, reflecting a lean, software-driven business model. - The partner is responsible for managing the inventory of sample collection kits (optional cost of GBP 7.5 per kit), requiring only a small fulfillment/warehouse space for storage and shipping. - We have successfully validated our technology on a global scale, processing over 50,000 microbiome samples across 15+ countries and securing strategic partnerships with major industry players. - Our deep-tech innovation has been recognized with prestigious global awards, including the UK Tech Rocketship Award and victories in the Sanofi and Bayer accelerator programs, establishing us as a trusted leader in the personalized health sector. - The business is driven by a seasoned leadership team, including a serial entrepreneur CEO and a CTO with 15+ years of bioinformatics expertise, ensuring clinical validity and robust architecture. - You can establish a high-margin, end-to-end health service by integrating our software with local Next-Generation Sequencing (NGS) laboratories. - In this model, our partner manages the complete value chain: collecting biological samples, processing them locally, and utilizing our AI to generate premium precision diet and health reports. - These complete diagnostic packages are then sold directly to consumers, medical clinics, and hospitals, allowing the partner to capture the full market value of every test performed. - Alternatively, you can leverage your exclusive regional rights to create a scalable B2B sublicensing ecosystem. - Acting as a master distributor, one can sublicense the software access to other local laboratories, wellness apps, and healthcare networks within the territory. - This allows to generate significant recurring revenue by charging own clients for API access or white-labeled portals, effectively monetizing the technology across the entire region without needing to manage every sample personally. - The company is headquartered in London, while the promoter is currently based in the US and has provided that number for all communications.

The company is selling perpetual usage rights of an AI platform that analyzes microbiome and health data to deliver personalized nutrition and wellness plans. - Partners can deploy and white-label the platform locally, offering premium, data-driven health solutions under their own brand. - The sale includes the proprietary core AI algorithms and source code for the microbiome-based precision diet technology. - Partners receive the right to unlimited API access and the ability to customize and train the AI with local data, ensuring relevance and effectiveness in their market. - The license also grants the right to localized deployment on the partner's local servers for compliance and security, and the autonomy to operate and brand the AI as their own. - The capacity of the AI model is virtually unlimited as it is scalable to the partner's server infrastructure, and its condition is excellent, being actively maintained by us. - The tangible assets required for the operation are minimal and fall primarily under the partner's operational responsibility, reflecting a lean, software-driven business model. - The partner is responsible for managing the inventory of sample collection kits (optional cost of GBP 7.5 per kit), requiring only a small fulfillment/warehouse space for storage and shipping. - We have successfully validated our technology on a global scale, processing over 50,000 microbiome samples across 15+ countries and securing strategic partnerships with major industry players. - Our deep-tech innovation has been recognized with prestigious global awards, including the UK Tech Rocketship Award and victories in the Sanofi and Bayer accelerator programs, establishing us as a trusted leader in the personalized health sector. - The business is driven by a seasoned leadership team, including a serial entrepreneur CEO and a CTO with 15+ years of bioinformatics expertise, ensuring clinical validity and robust architecture. - You can establish a high-margin, end-to-end health service by integrating our software with local Next-Generation Sequencing (NGS) laboratories. - In this model, our partner manages the complete value chain: collecting biological samples, processing them locally, and utilizing our AI to generate premium precision diet and health reports. - These complete diagnostic packages are then sold directly to consumers, medical clinics, and hospitals, allowing the partner to capture the full market value of every test performed. - Alternatively, you can leverage your exclusive regional rights to create a scalable B2B sublicensing ecosystem. - Acting as a master distributor, one can sublicense the software access to other local laboratories, wellness apps, and healthcare networks within the territory. - This allows to generate significant recurring revenue by charging own clients for API access or white-labeled portals, effectively monetizing the technology across the entire region without needing to manage every sample personally. - The company is headquartered in London, while the promoter is currently based in the US and has provided that number for all communications.

Industrial land is available for sale in Pilkhuwa. - The plot is spread across an area of 34,000 sq ft. It is a north-facing property with a front-facing road width of 221 ft. - It is available for immediate possession. - The land can be developed and can be used to start any SME industry. - Facilities like water and electricity are available in the area and are connected with government drainage. -Major banks, ATMs, hospital, and the market is located within a close radius. - Eastern peripheral expressway is just 10 minutes away. - The land is 30 minutes away from Delhi and has easy access to public transport. - The promoter owns the land. - The land is not owned by the company.

The hotel is located on Mathiveri Island in the Maldives, a popular tourist destination known for its scenic beauty, making it an attractive location for a hospitality and tourism business. - Hotel has 25-30 rooms, a restaurant, and a swimming pool, with a land area of 1.5 hectares and a built-up area of 5,000 square feet, providing a beachfront property with 3 floors. - Hotel currently boasts a 65-70% occupancy rate throughout the year, with monthly sales of USD 56,000, indicating a steady and profitable operation. - With the charge per night ranging from USD 100 to 150, and the potential for increased rates during peak seasons, the business demonstrates a strong potential for revenue generation and profit growth. - Property is available for long-term lease, offering a lease term of 25 to 75 years, providing stability and potential for sustained income for the lessee. - We are not charging any security deposit. - Business is owned outright by the promoter, with no existing loans on the property. - The property is ready for immediate operations, presenting an opportunity for an investor to seamlessly transition into the hospitality and hotels industry. - Need an operating license, TGST license and Green Tax license to operate and the promoter will help in getting these approvals and licences.

Looking to lease out an industrial shed/warehouse which is located at a prime industrial area Mhalunge, Chakan, Pune, Maharashtra. - Chakan is an automobile hub and is 30 kms away from Pune, which makes the property at the most preferred location and is road touching state highway. - The factory shed /warehouse is immediately available for lease. Located in a heart of industrial area the property enjoys a favourable location in terms of footfall, and business. - It is close to world renowned automobile companies as Mercedes Benz, Volkswagan, Mahindra, and Bajaj Auto. - Configurations of the factory shed/ warehouse are the property is stretched across a carpet area of 6,000 sq. ft. , which comprises of 2 washrooms. - The construction is world class peb with 3 ton crane provision, 65 HP power which is upgradable, and water line from Maharashtra Industrial Development Corporation (MIDC) with storage available. - The property has all legal sanctions and is state of art construction. - The property is located close to Chakan, Talegaon road, and state highway, which provides access to transportation, and proper security. - The property is suitable for light industry, commercial purpose, such as godown, storage of inventory goods, etc. - The reliable auto components on road are easily accessible by any mode of transport, strategically located, this property is at one of the most preferred business location.

Looking to sell online rummy and poker gaming application, that is totally legal in India. - The buyer would get the gaming software. - The website and the application are ready but have not been launched on App Store and Google Play yet. - It has been non-operational and there are no players. - The application has been tested but due to the pandemic, the company's director has not been able to focus on it. - The software is in the marketing stage and it just needs proper marketing & advertisement to run the business. - Online gaming industry is a profitable venture and can scale very well in the era of internet. - The application has been developed using a white label software.

Generic pharmaceuticals manufacturing facility located in Rewari is available for long-term lease. - The factory comprises a built area of 1,500 sqm over two floors (G+1) and includes additional mezzanine and terrace areas. - Equipped with a non-beta lactum section for manufacturing tablets and capsules, ensuring compliance with industry standards. - The facility includes approximately 20-25 manufacturing machines valued at INR 5 crore, providing a comprehensive production setup. - The total land size is 1,000 sqm, with the land and building appraised at INR 10 crore, making it a significant asset for investors. - The factory meets the revised Schedule M standards essential for pharmaceutical manufacturing, guaranteeing adherence to regulatory requirements. - The facility is aimed at pharmaceutical companies looking to outsource production or expand their manufacturing capabilities in the generic medication sector. - The business generates income through long-term leases of the factory space, providing a lucrative opportunity for investors in the growing generic pharmaceuticals market.

We are leasing a patent license for the herbal formula developed by us to treat Covid-19 and other viral/respiratory illnesses. - Formulations can be used safely on adults and children (3yrs +). - Patent includes research, two herbal formulations, and a unique intermittent fasting method designed to quickly rid the body of toxins. - Currently in the pre-IND phase with the U. S. FDA for clinical trials. - Advance payment for the patent of USD $20 million, 10% royalties thereafter for 10-20 year term (negotiable). - Potential companies must have a solid track record in the nutraceutical industry, strong supply chain, and the ability to reach emerging markets for traditional medicine particularly in China and India. - Additional information is available upon request and after signing the NDA.

A restaurant chain in Thailand that started operations in 2012. - Currently, have set up 12 branches and are already set to expand our footprint in Thailand with 50 new branch openings. - Industry leader in cost margins due to supply chain strengths. Gross product profit margin reaches up to 80% on popular items. - Lucky 13 Sandwich is a new generation business structure that is ready for the new industrial revolution that is upon us.